Assertio Holdings (ASRT) Non-Current Debt (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Non-Current Debt came in at $39.2 million in Q1 2026, up 0.82% year-on-year from $38.9 million in Q1 2025, and little changed quarter-over-quarter from $39.1 million in Q4 2025.

Assertio Holdings (ASRT) Non-Current Debt (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Non-Current Debt across 8 years of filings, most recently posting $39.2 million for Q1 2026.

  • Non-Current Debt for Q1 2026 came in at $39.2 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.2 million (up 0.82% YoY), and the FY2025 annual result was $39.1 million, up 0.8% from the prior year.
  • Non-Current Debt came in at $39.2 million for Q1 2026 at Assertio Holdings, roughly flat from $39.1 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $66.4 million in Q4 2022 to a low of $38.2 million in Q1 2023.
  • The 5-year median for Non-Current Debt is $38.9 million (2025), against an average of $44.0 million.
  • Across the five-year window, Non-Current Debt gained 8.29% in 2022 and slumped 42.0% in 2023, its largest moves.
  • Assertio Holdings' Non-Current Debt stood at $66.4 million in 2022, then plunged by 42.0% to $38.5 million in 2023, then advanced by 0.78% to $38.8 million in 2024, then gained by 0.8% to $39.1 million in 2025, then gained by 0.32% to $39.2 million in 2026.
  • The last three Non-Current Debt figures came in at $39.2 million (Q1 2026), $39.1 million (Q4 2025), and $39.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 14.02 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 9.05 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 3.92 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.48 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 569.60 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 39.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.25 Mn
Mar 31, 2026 39.25 Mn
Dec 31, 2025 39.12 Mn
Dec 31, 2025 39.12 Mn
Sep 30, 2025 39.17 Mn
Sep 30, 2025 39.17 Mn
Jun 30, 2025 39.05 Mn
Jun 30, 2025 39.05 Mn
Mar 31, 2025 38.93 Mn
Mar 31, 2025 38.93 Mn
Dec 31, 2024 38.81 Mn
Dec 31, 2024 38.81 Mn
Sep 30, 2024 38.84 Mn
Sep 30, 2024 38.84 Mn
Jun 30, 2024 38.73 Mn
Jun 30, 2024 38.73 Mn
Mar 31, 2024 38.62 Mn
Mar 31, 2024 38.62 Mn
Dec 31, 2023 38.51 Mn
Dec 31, 2023 38.51 Mn